Stock in Focus: Edwards Lifesciences Corporation (NYSE: EW)

On Monday, Shares of Edwards Lifesciences Corporation (NYSE: EW) showed the bullish trend with a higher momentum of 0.45% to $184.75. The company traded total volume of 1.068M shares as contrast to its average volume of 1.25M shares. The company has a market value of $38.67B and about 209.31M shares outstanding.

Edwards Lifesciences Corp. (EW) stated first-quarter earnings of $249.70M. On a per-share basis, the Irvine, California-based company said it had net income of $1.18. Earnings, adjusted for non-recurring costs, were $1.32 per share. The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.23 per share.

The medical device maker posted revenue of $9930M in the period, also surpassing Street forecasts. Eight analysts surveyed by Zacks expected $988.90M. For the current quarter ending in July, Edwards Lifesciences anticipates its per-share earnings to range from $1.27 to $1.37. The company said it anticipates revenue in the range of $1.020B to $1.080B for the fiscal second quarter. Edwards Lifesciences anticipates full-year earnings in the range of $5.10 to $5.35 per share, with revenue ranging from $3.90B to $4.30B.

Related:  Relief Therapeutics (RLFTF) Pulls Back From This Week Rally: How to Trade Now?

The Company offered net profit margin of 20.00% while its gross profit margin was 75.50%. ROE was recorded as 23.30% while beta factor was 0.86. The stock, as of recent close, has shown the weekly downbeat performance of -0.26% which was maintained at 20.62% in this year.

Jack Dawkins

Finance and Tech Contributor